Skip to main content

Table 3 Reversion and non-reversion of QFT-IT among ESRD patients with 1st QFT-IT positive result

From: Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population

ESRD patients (N = 39) Reversion Non-reversion OR (95 % CI) P value
Dialysis method      
  PD 7 (35.0 %) 13 (65.0 %) 9.7 (1.1–88.7) 0.04
  HD 1 (5.3 %) 18 (94.7 %) 1 (Ref.)  
Treatment      
  LTBI treatment 5 (27.8 %) 13 (72.2 %) 2.3 (0.5–11.4) 0.43
  No LTBI Treatment 3 (14.3 %) 18 (85.7 %) 1 (Ref.)  
Treatment drug      
  Rifampin 3 (37.5 %) 5 (62.5 %) 2.4 (0.3–19.8) 0.61
  INH 2 (20.0 %) 8 (80.0 %) 1 (Ref.)  
  1. OR odds ratio, PD peritoneal dialysis, HD hemodialysis, LTBI latent tuberculosis infection, RFP rifampicin, INH isoniazid